Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.

Keating, S; Suciu, S; de Witte, T; Mandelli, F; Willemze, R; Resegotti, L; Broccia, G; Thaler, J; Labar, B; Damasio, E; Bizzi, B; Rotoli, B; Vekhoff, A; Muus, P; Petti, M C; Dardenne, M; Solbu, G; Vegna, M L; Zittoun, R A

Keating, S; Suciu, S; de Witte, T; Mandelli, F; Willemze, R; Resegotti, L; Broccia, G; Thaler, J; Labar, B; Damasio, E; Bizzi, B; Rotoli, B; Vekhoff, A; Muus, P; Petti, M C; Dardenne, M; Solbu, G; Vegna, M L; Zittoun, R A.

Keating S; Department of Hematology of 12Hôtel-Dieu, Paris, France.

Bone Marrow Transplant ; 17(6): 993-1001, 1996 Jun.

Article en En | MEDLINE | ID: mdl-8807105

Asunto(s)

Trasplante de Médula Ósea; Leucemia Mieloide Aguda/terapia; Adolescente; Adulto; Aberraciones Cromosómicas; Femenino; Humanos; Leucemia Mieloide Aguda/sangre; Leucemia Mieloide Aguda/genética; Masculino; Persona de Mediana Edad; Pronóstico; Estudios Prospectivos; Acondicionamiento Pretrasplante; Trasplante Homólogo

Search on Google

Imprimir

XML

PubMed Links

Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Médula Ósea Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Año: 1996 Tipo del documento: Article

Search on Google

Imprimir

XML

PubMed Links